IMR Press / CEOG / Volume 45 / Issue 1 / DOI: 10.12891/ceog3768.2018

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Case Report
Microwave endometrial ablation may be an ineffective procedure for life-threatening uterine bleeding induced by an uterine arteriovenous malformation
Show Less
1 Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Japan
Clin. Exp. Obstet. Gynecol. 2018, 45(1), 132–134; https://doi.org/10.12891/ceog3768.2018
Published: 10 February 2018
Abstract

Microwave endometrial ablation (MEA) is effective for the emergent control of uterine hemorrhage. No cases involving life-threatening hemorrhage induced by a uterine arteriovenous malformation (UAVM) treated by MEA have been reported. In the current case, the authors evaluated the efficacy of MEA as a first-line therapeutic option for a bleeding UAVM; however, MEA was ineffective in controlling the bleeding induced by the UAVM. Given its safety, simplicity, and effectiveness, MEA has been widely adopted for the emergency control of uterine bleeding; however, MEA should be used with extreme caution for the treatment of intractable bleeding induced by uterine AVM. Although MEA is thought be a highly efficacious way to urgently control life-threatening uterine hemorrhage, MEA should be used for the treatment of UAVMs with extreme caution.
Keywords
MEA
UAVM
Life threatening uterine bleeding
Share
Back to top